{
  "ticker": "GLTO",
  "company": "Galecto, Inc.",
  "cik": "0001800315",
  "exchange": null,
  "gics_sector": "Health Care",
  "industry": "Health Care",
  "logo_url": "https://www.google.com/s2/favicons?domain=galecto.com&sz=128",
  "from_state": "DE",
  "to_state": "Cayman Islands",
  "effective_date_iso": "2026-02-09",
  "actual_effective_date_iso": "2026-02-09",
  "proposed_effective_date_iso": null,
  "source_confidence": "VERIFIED_PROXY",
  "is_legal_precedent": 0,
  "vote_mechanism": null,
  "approval_basis": "For \u00f7 outstanding voting power (DGCL \u00a7266 conversion to Cayman Islands \u2014 comparator)",
  "threshold_result": null,
  "event_type": null,
  "two_attempt_flag": 0,
  "prior_failed_vote_flag": 0,
  "governance_concession_redo_flag": 0,
  "subsequent_event_flag": 0,
  "subsequent_event_type": null,
  "subsequent_event_date_iso": null,
  "subsequent_event_note": null,
  "public_tier": "VERIFIED_TRACKER",
  "event_study_announcement_json": "{\"event_date\":\"2025-08-20\",\"event_kind\":\"announcement\",\"event_tag\":\"announcement\",\"t0_source_field\":\"announcement_date_iso\",\"estimation_window\":\"trailing 240 days; 240 valid after NaN drop\",\"specifications\":[{\"name\":\"Market model (SPY benchmark)\",\"day0_ar\":0.011917187973448283,\"p_value\":0.8415206481136985,\"p_label\":\"Patell-z p-value\",\"extra\":{\"alpha\":-0.004306046668461689,\"beta\":1.7589199257262018,\"r2\":0.1217112324372096,\"sigma\":0.05946837847021589},\"is_headline\":true}],\"_meta\":{\"n_valid_pre_days\":240},\"_source\":\"Source B: phase4v3 NaN-safe runner (1 spec, 2026-04-29 yfinance pull); Source A unavailable for this firm; joined by phase5z_join_full_battery.py\"}",
  "announcement_date_iso": "2025-08-20",
  "meeting_date_iso": "2025-10-22",
  "vote_result": "APPROVED",
  "status_label": "APPROVED",
  "market_cap_usdmm": 32.0,
  "bucket_class": "Y",
  "public_bucket_code": "Y",
  "public_bucket_label": "Comparator (DE-outbound to non-TX/NV)",
  "public_bucket_subcode": null,
  "panel_eligibility": "PANEL_A_post_SB29_non_TX_NV",
  "transaction_status": "COMPLETED",
  "audit_status": "VERIFIED_EDGAR",
  "audit_notes": "| v2.9.2: outbound POST-SB29 to non-TX/NV destination; reclassified A\u2192Z (out of SB29 scope per BLP corroboration) | v2.9.3: bucket_Y=1 (revealed-preference comparator: DE leaver post-SB29 to non-TX/NV destination) | [2026-04-28] Phase 4I: replaced Google-search IR fallback with direct URL https://investors.galecto.com/\n[2026-04-29] phase5k T1: GLTO effective_missing -> 2026-02-09 from 8-K Item 5.03 (acc 0001193125-26-043741); source: https://www.sec.gov/Archives/edgar/data/1800315/000119312526043741/glto-20260206.htm\n[2026-04-29] phase5k T2: GLTO vote_source_8k from 8-K (acc 0001193125-26-043741); source: https://www.sec.gov/Archives/edgar/data/1800315/000119312526043741/glto-20260206.htm\n[2026-04-29] phase5k T2: GLTO vote_source_8k_url paired with acc 0001193125-26-043741; source: https://www.sec.gov/Archives/edgar/data/1800315/000119312526043741/glto-20260206.htm\n[2026-04-29] phase5w: comprehensive validation by external reviewer across tranches v3 (4-version full residual walk, 269 substantive answers across 52 firms, 0 bucket drifts vs v3.58)\n[2026-04-29] phase5x: Decision #1 per Shane 2026-04-29 -- Y-bucket firms (DE->non-TX/NV) remain in dashboard cohort (flag=1) as revealed-preference comparators; the 'why others left DE' question matters even if destination isn't TX or NV | [2026-04-29] v3.75: VERIFIED via 8-K \u2014 DELAWARE \u2192 CAYMAN ISLANDS (NOT TX/NV \u2014 comparator/Bucket Y, same class as CDT). Special meeting February 9, 2026 approved Cayman conversion + Series B/C conversion + 300M\u2192500M authorized shares + 2026 equity plans. Rebranded to Damora Therapeutics (DMRA) March 10, 2026. Item 5.07 vote-tally pincite pending.",
  "edgar_accession": null,
  "edgar_accession_note": null,
  "links": [
    {
      "label": "IR",
      "url": "https://investors.galecto.com/",
      "link_type": "ir"
    },
    {
      "label": "EDGAR",
      "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001800315&type=&dateb=&owner=include&count=40",
      "link_type": "search"
    },
    {
      "label": "Proxy",
      "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001800315&type=DEF+14A&dateb=&owner=include&count=40",
      "link_type": "search"
    }
  ],
  "car": {
    "value": 0.2258165211399659,
    "pvalue": 0.04761904761904762,
    "significant_5pct": 1,
    "specification": "synthetic_control",
    "event_date": "2026-02-09",
    "event_tag": "vote_date",
    "confound": "MEDIUM",
    "placebo_ratio": 0.961370079972693,
    "pre_rmspe": 0.1544293318605341,
    "source": "Event_Studies/results/per_firm_event_study.csv",
    "status": "ESTIMATED",
    "vote": {
      "value": 0.2258165211399659,
      "pvalue": 0.04761904761904762,
      "specification": "synthetic_control",
      "event_date": "2026-02-09"
    }
  },
  "votes_for": null,
  "votes_against": null,
  "votes_abstain": null,
  "votes_broker_nonvote": null,
  "approval_pct": null,
  "votes_for_disinterested": null,
  "votes_against_disinterested": null,
  "votes_abstain_disinterested": null,
  "votes_broker_nonvote_disinterested": null,
  "approval_pct_disinterested": null,
  "approval_basis_disinterested": null,
  "announcement_PRE_14A_accession": null,
  "announcement_PRE_14A_url": null,
  "vote_source_8k_accession": "0001193125-26-043741",
  "vote_source_8k_url": "https://www.sec.gov/Archives/edgar/data/1800315/000119312526043741/glto-20260206.htm",
  "vote_proposal_title": null,
  "meeting_type": null,
  "approval_standard": "majority of outstanding shares entitled to vote (DGCL \u00a7266 conversion to Cayman Islands)",
  "companion_proposal": null,
  "proxy_advisors": null,
  "management_response": null,
  "press_coverage": [],
  "prior_vote": null,
  "panel_a_tx_incumbent": 0,
  "panel_b_dexit_mover": 0,
  "texas_statutory_adoptions": {
    "tboc_21_552": {
      "name": "SB 29 \u2014 TBOC \u00a721.552 derivative threshold",
      "adopted": 0,
      "source": null,
      "url": null,
      "date": null
    },
    "tboc_21_373": {
      "name": "SB 1057 \u2014 TBOC \u00a721.373 shareholder-proposal threshold",
      "adopted": null,
      "source": null,
      "url": null,
      "date": null
    }
  },
  "announcement_source_type": null,
  "announcement_accession_verified": "N",
  "date_quality_flag": "LOW",
  "_evidence_strength": {
    "badge": "BRONZE",
    "score": 50,
    "max": 100,
    "components": {
      "source_confidence": 20,
      "vote_totals": 0,
      "effective_date": 20,
      "car_estimate": 10,
      "edgar_accession": 0
    }
  },
  "_context_callout": "Destination is Cayman Islands \u2014 an outbound move to a non-TX/NV jurisdiction. Retained as a revealed-preference comparator (Y bucket) rather than included in completed-DExit counts.",
  "_generated_at": "2026-04-30"
}